Comparison of Two Different Accelerated Corneal Cross-linking Procedure Outcomes in Patients with Keratoconus

Comparison of Two Different Accelerated Corneal Cross-linking Procedure Outcomes in Patients with Keratoconus

Background: Corneal cross-linking treatment is the unique treatmentmethod that can cease the progression of keratoconus disease.Because of the long duration of conventional treatment, acceleratedcross-linking treatment methods are being developed.Aims: To compare two different accelerated corneal cross-linkingprotocols in terms of postoperative visual acuity and topographicfindings (higher-order aberrations and keratometry values).Study Design: Retrospective comparative study.Methods: Sixty-five eyes of 43 patients (30 men and 13 women)who underwent two different accelerated corneal cross-linkingprotocols (10 min, 9 mW/cm2 and 5 min, 18 mW/cm2) for progressivekeratoconus were retrospectively analyzed. Patients were dividedinto two groups according to the accelerated corneal cross-linkingtreatment protocol: group 1 (10 min, 9 mW/cm2, 32 eyes of 21patients) and group 2 (5 min, 18 mW/cm2, 33 eyes of 22 patients).Uncorrected visual acuity and best-corrected visual acuity values andtopographic findings (central corneal thickness and flat and steepkeratometry values) were recorded preoperatively and 6 monthsafter corneal cross-linking treatment. High-order aberration valuesmeasured with Pentacam preoperatively and 6 months after cornealcross-linking were also recorded.Results: In both groups, a significant improvement was detected inthe uncorrected visual acuity and best-corrected visual acuity levelspreoperatively and 6 months postoperatively (group 1: p=0.001,p=0.001 and group 2: p=0.001, p=0.001, respectively). In addition,central corneal thickness values decreased significantly in both groups(p=0.006 and 0.001). Trefoil values showed no significant differencepreoperatively and 6 months postoperatively in group 1 (p=0.160and 0.620, respectively). In groups 1 and 2, coma values were foundto decrease significantly in the 6th postoperative month comparedwith preoperative values (p=0.001 and 0.020, respectively). Therewas no significant difference between preoperative and 6th monthpostoperative horizontal and vertical trefoil values in both groups(p=0.850 and 0.140, respectively). There was no significant differencebetween the two groups in terms of preoperative and 6th monthpostoperative higher-order aberrations, refractive errors, keratometryvalues, and uncorrected visual acuity and best-corrected visual acuitylevels.Conclusion: Both accelerated corneal cross-linking proceduresprovide similar improvement in topographic findings, coma valuesand visual acuity

___

  • 1. Galvis V, Sherwin T, Tello A, Merayo J, Barrera R, Acera A. Keratoconus: an inflammatory disorder? Eye (Lond) 2015;29:843-59.
  • 2. Or H. An Up-To-Date View at the Etiopathogenesis of Keratoconus. Turk J Ophthalmol 2011;41:339-47.
  • 3. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res 1998;66:97-103.
  • 4. Parkin BT, Smith VA, Easty DL. The control of matrix metalloproteinase-2 expression in normal and keratoconic corneal keratocyte cultures. Eur J Ophthalmol 2000;10:276-85.
  • 5. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet- a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003;135:620-7.
  • 6. Hafezi F, Mrochen M, Iseli HP, Seiler T. Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas. J Cataract Refract Surg 2009;35:621-4.
  • 7. Hammer A, Richoz O, Arba Mosquera S, Tabibian D, Hoogewoud F, Hafezi F. Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci 201455:2881-4.
  • 8. Maeda N, Fujikado T, Kuroda T, Mihashi T, Hirohara Y, Nishida K, et al. Wavefront aberrations measured with Hartmann-Shack sensor in patients with keratoconus. Ophthalmology 2002;109:1996-2003.
  • 9. Polat N, Aydın EY, Tuncer I. Optic aberrations and wavefront. Turkish Journal Ophthalmology 2014;44:306-11.
  • 10. Vinciguerra P, Albe E, Trazza S, Rosetta P, Vinciguerra R, Seiler T, et al. Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. Ophthalmology 2009;116:369–78.
  • 11. Hersh PS, Greenstein SA, Fry KL. Corneal collagen crosslinking for keratoconus and corneal ectasia: one year results. J Cataract Refract Surg 2011;37:149–60.
  • 12. Sherif AM. Accelerated versus conventional corneal collagen cross-linking in the treatment of mild keratoconus: a compara- tive study. Clin Ophthalmol 2014;8:1435-40.
  • 13. Gautam, Jhanji V, Satpathy G, Khokhar S, Agarwal T. Microsporidial keratitis after collagen cross-linking. Ocul Immunol Inflamm 2013;21:495-7.
  • 14. Brindley GS. The Bunsen-Roscoe law for the human eye at very short durations. J Physiol 1952;118:135–9.
  • 15. Schumacher S, Oeftiger L, Mrochen M. Equivalence of biomechanical changes induced by rapid and standard corneal cross-linking, using riboflavin and ultraviolet radiation. Invest Ophthalmol Vis Sci 2011;52:9048–52.
  • 16. Tomita M, Mita M, Huseynova T. Accelerated versus conventional corneal collagen crosslinking. J Cataract Refract Surg 2014;40:1013–20.
  • 17. Wernli J, Schumacher S, Spoerl E, Mrochen M. The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV light and short treatment time. Invest Ophthalmol Vis Sci 2013;54:1176-80.
  • 18. Huang R, Choe E, Min DB. Kinetics for singlet oxygen formation by riboflavin photosensitization and the reaction between riboflavin and singlet oxygen. J Food Sci 2004;69:C726-C32.
  • 19. Vinciguerra P. The efficacy of corneal cross-linking shows a sudden decrease with very high intensity UV lightand short treatment time. Invest Ophthalmol Vis Sci 2013;54.
  • 20. Kirgiz A, Eliacik M, Yildirim Y. Different accelerated corneal collagen cross-linking treatment modalities in progressive keratoconus. Eye Vis (Lond) 2019;6:16.
  • 21. Choi M, Kim J, Kim EK, Seo KY, Kim TI. Comparison of the conventional Dresden protocol and accelerated protocol with higher ultraviolet intensity in corneal collagen cross-linking for keratoconus. Cornea 2017;36:523–9. 22. Hashemi H, Mohebbi M, Asgari S. Standard and accelerated corneal cross-linking longterm results: A randomized clinical trial. Eur J Ophthalmol 2019:1120672119839927.
  • 23. Kato N, Konomi K, Shinzawa M, Kasai K, Ide T, Toda I, et al. Corneal crosslinking for keratoconus in Japanese populations: one year outcomes and a comparison between conventional and accelerated procedures. Jpn J Ophthalmol 2018;62:560-7.
  • 24. Yildirim Y, Olcucu O, Gunaydin ZK, Ağca A, Ozgurhan EB, Alagoz C, et al. Comparison of accelerated corneal collagen cross-linking types for treating keratoconus. Curr Eye Res 2017;42:971–5.
  • 25. Schlegel Z, Lteif Y, Bains HS, Gatinel D. Total, corneal, and internal ocular optical aberrations in patients with keratoconus. J Refract Surg 2009;25(10 Suppl):S951–7.
  • 26. Alió JL, Shabayek MH. Corneal higher order aberrations: a method to grade keratoconus. J Refract Surg 2006;22:539–45.
  • 27. Greenstein SA, Fry KL, Hersh MJ, Hersh PS. Higher-order aberrations after corneal collagen crosslinking for keratoconus and corneal ectasia. J Cataract Refract Surg 2012;38:292-302
  • 28. Kocamış Sİ, Çakmak HB, Uğurlu N, Çağıl N. Keratokonusta Çapraz Bağlama Tedavisinin Konus Kırıcılığı ve Yüksek Sıralı Korneal Aberasyonlar Üzerine Etkisi. Turk J Ophthalmol 2014;44:184-9.
  • 29. Caporossi A, Mazzotta C, Baiocchi S, Caporossi T. Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol 2010;149:585-93.
  • 30. Baumeister M, Klaproth OK, Gehmlich J, Bühren J, Kohnen T. Changes in corneal first-surface wavefront aberration after corneal collagen cross-linking in keratoconus. Klin Monbl Augenheilkd 2009;226:752-6.
Balkan Medical Journal-Cover
  • ISSN: 2146-3123
  • Başlangıç: 2015
  • Yayıncı: Erkan Mor
Sayıdaki Diğer Makaleler

Comparison of Two Different Accelerated Corneal Cross-linking Procedure Outcomes in Patients with Keratoconus

Hasan KIZILTOPRAK, Emre AYDEMİR, Gözde AKSOY AYDEMİR, Kemal ÖZÜLKEN, Erdem YÜKSEL

Trends and Causes of Neonatal Mortality in Serbia, 1997-2016

Konstansa LAZAREVİĆ, Dragan BOGDANOVİĆ, Ljiljana STOŠİĆ

Atrial Mass Versus Thrombus

Yugandhara KATE, Masood Pasha SYED, Shekhar PATIL, Deepti KUMAR, Adhirath DASHI

Molecular Identification of HIV-1 in the Presence of Hepatitis B Virus and Hepatitis C Virus Co-infections

Aydın DEVECİ, Nurgül CERAN, Servet ÖZTÜRK, Alper GÜNDÜZ, Selda SAYIN KUTLU, Ayhan AKBULUT, Saadet YAZICI, Dilara İNAN, Atahan ÇAĞATAY, Taner YILDIRMAK, Yasemin HEPER, Hülya ÖZKAN ÖZDEMİR, Figen SARIGÜL YILDIRIM, Gülden ERSÖZ, Murat SAYAN, İlkay KARAOĞLAN, Alper ŞENER, Mustafa Kemal ÇELEN, Müge ÖZGÜL

The Geographical Distribution of Morbidity Caused By Chronic Obstructive Pulmonary Disease in Turkey: COPDTURKEY-2

Can ÖZTÜRK, Tarkan ÖZDEMİR, Orhan KOÇ, Çiğdem ÖZDİLEKCAN, Hatice KILIÇ, H. Canan HASANOĞLU, Mustafa Hamidullah TÜRKKANI, Nilgün YILMAZ DEMİRCİ

A Liver Transplant Patient on Everolimus Treatment Presented with Acute Anterior Myocardial Infarction: Does the Type of Drug-eluting Stent Matter?

Servet ALTAY, Muhammet GÜRDOĞAN, Mustafa Adem YILMAZTEPE, Ömer Ferudun AKKUŞ, Kenan YALTA

Plasma Histone H4 and Its Implications in the Setting of Sepsis-related Myocardial Dysfunction

Kenan YALTA, Muhammet GÜRDOĞAN

Optic Neuritis as an Isolated Presentation of Kikuchi–Fujimoto Disease in a Pediatric Patient

Izlem IZBUDAK, Aydan ARSLAN, Courtney Lynn KRAUS

Meckel’s Extraordinary Complication

Yeliz ARMAN KARAKAYA, Osman UZUNLU

The Impact of Pre-transplant Cell-free DNA Levels on Leukemia Relapse and Transplant-related Complications in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Zübeyde Nur ÖZKURT, Ferda CAN, Münci YAĞCI, Zeynep Arzu YEGİN, Sanem GÖKÇEN, Rezzan Eren SADİOĞLU, Çiğdem İLHAN